RETROSPECTIVE APPLICATION OF A SET OF CLINICAL DIAGNOSTIC-CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SYSTEM ATROPHY

Citation
I. Litvan et al., RETROSPECTIVE APPLICATION OF A SET OF CLINICAL DIAGNOSTIC-CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SYSTEM ATROPHY, Journal of neural transmission, 105(2-3), 1998, pp. 217-227
Citations number
32
Categorie Soggetti
Clinical Neurology",Neurosciences
ISSN journal
03009564
Volume
105
Issue
2-3
Year of publication
1998
Pages
217 - 227
Database
ISI
SICI code
0300-9564(1998)105:2-3<217:RAOASO>2.0.ZU;2-3
Abstract
We estimated the accuracy of a modified commonly used set of clinical diagnostic criteria for the diagnosis of multiple system atrophy (MSA) by retrospectively applying the criteria to the features recorded by six neurologists who had evaluated 105 autopsy-confirmed cases (16 MSA and 89 non-MSA disorders). Cases were abstracted from the records of the patients' first visit to an academic center: and were presented as clinical vignettes to six neurologists, each of whom recorded the mai n clinical features of the presented clinical vignette on a standardiz ed form. Sensitivity and positive predictive values were chosen as val idity outcome measures and were calculated by comparing the applied di agnostic criteria to the neuropathologic information. Of note, most MS A patients in this study (mainly those with Shy-Drager type) had not r eceived levodopa therapy since the primary neurologists often had not perceived a need to administer this treatment. The validity of the ret rospectively applied criteria for the diagnosis of possible MSA (sensi tivity: median, 53%, range, 50-69%; positive predictive value: 30%, 28 -39%) and probable MSA (sensitivity: 44%, 31-60%; positive predictive value: 68%, 54-80%) at the first visit was suboptimal. The best, still not perfect, accuracy for this set of diagnostic criteria was obtaine d when six out of eight features (sporadic adult onset, dysautonomia, parkinsonism, pyramidal signs, cerebellar signs, no levodopa response, no cognitive dysfunction, or no downward gaze supranuclear palsy) wer e present (median sensitivity, 59%; range, 50-75%; positive predictive value: 67%, 53-83%). This is the first study to validate criteria for the clinical diagnosis of MSA. Our data suggest that it is difficult to achieve an early and accurate clinical diagnosis of this disorder. The probability of correctly diagnosing MSA increases when at least si x features of this modified set of criteria are present or when requir ing the set for probable MSA.